FOXP3 and breast carcinoma: To this end, we obtained FFPE tumor tissue from the same breast cancer patients assessed before for TCR clonality in PB (Fig. 2c) and performed Immunofluorescence analysis on serial tissue sections against CD4, FOXP3, and CD127 (Fig. 6a).